Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
947.8 USD | +3.86% | +3.77% | +21.00% |
05-14 | US companies with highest exposure to China | RE |
05-13 | Jefferies Adjusts Price Target on Lam Research to $1,100 From $980, Assumes Buy Rating | MT |
Sales 2024 * | 14.87B 20.23B | Sales 2025 * | 17.66B 24.02B | Capitalization | 124B 169B |
---|---|---|---|---|---|
Net income 2024 * | 3.77B 5.12B | Net income 2025 * | 4.63B 6.29B | EV / Sales 2024 * | 8.27 x |
Net cash position 2024 * | 850M 1.16B | Net cash position 2025 * | 1.1B 1.49B | EV / Sales 2025 * | 6.95 x |
P/E ratio 2024 * |
33.2
x | P/E ratio 2025 * |
27.1
x | Employees | 17,200 |
Yield 2024 * |
0.83% | Yield 2025 * |
0.89% | Free-Float | 44.18% |
Latest transcript on Lam Research Corporation
1 day | +3.86% | ||
1 week | +3.77% | ||
Current month | +5.96% | ||
1 month | +0.17% | ||
3 months | +3.72% | ||
6 months | +35.80% | ||
Current year | +21.00% |
Managers | Title | Age | Since |
---|---|---|---|
Timothy Archer
CEO | Chief Executive Officer | 57 | 12-06-03 |
Director of Finance/CFO | 56 | 13-03-10 | |
Robert Hawthorne
CTO | Chief Tech/Sci/R&D Officer | - | 19-01-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Leslie Varon
BRD | Director/Board Member | 67 | 19-05-08 |
Chairman | 60 | 11-01-31 | |
Eric Brandt
BRD | Director/Board Member | 62 | 10-08-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
4.29% | 1 M€ | -.--% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-15 | 947.8 | +3.86% | 713,366 |
24-05-14 | 912.5 | +0.97% | 575,050 |
24-05-13 | 903.8 | -1.27% | 739,399 |
24-05-10 | 915.4 | +0.87% | 510,042 |
24-05-09 | 907.5 | -0.63% | 576,721 |
Delayed Quote Nasdaq, May 15, 2024 at 04:00 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+21.00% | 119B | |
+24.83% | 357B | |
+44.01% | 102B | |
+11.85% | 19.89B | |
+52.80% | 11.25B | |
+33.07% | 9.44B | |
+1.53% | 8.2B | |
-26.26% | 5.85B | |
+30.27% | 5.21B | |
+31.38% | 4.25B |
- Stock Market
- Equities
- LRCX Stock